Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

"Skyrizi"
Topics

Advertisement

Advertisement

"Skyrizi"

Showing articles that match "Skyrizi" in the headline

Yesterday

Be bold: Bimzelx® (bimekizumab-bkzx) builds on superior joint responses versus Skyrizi® (risankizumab-rzaa) at Week 16, with clinical improvements sustained through Week 24 PR Newswire (Press Release) 12:07 Mon, 09 Nov

In the last month

Looking For Bolt-Ons, Pushing Skyrizi/Rinvoq: Five Things To Know From AbbVie’s Q3 Scrip Pharma Intelligence 22:03 Fri, 30 Oct

Supplements and Liver Injury; New Skyrizi Approval in Crohn's; Preventing C. Diff Medpage Today 19:26 Thu, 29 Oct

Advertisement

Advertisement

At-Home Skyrizi Induction Approved for Crohn's After 56% Reached Clinical Remission at 12 Weeks Versus 30% on Placebo Medical Daily 10:15 Mon, 26 Oct

U.S. FDA Approves Subcutaneous Induction Regimen for AbbVie's Skyrizi® (risankizumab-rzaa) for Adults With Moderately to Severely Active Crohn's Disease PR Newswire (Press Release) 20:35 Fri, 23 Oct

Skyrizi® (risankizumab) and Rinvoq® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at Uegw 2026 PR Newswire (Press Release) 07:02 Sat, 17 Oct

AbbVie Presents New Phase 3 affirm Data Showing Clinical and Endoscopic Outcomes With Subcutaneous Skyrizi® (risankizumab-rzaa) in Patients With Moderately to Severely Active Crohn's Disease PR Newswire (Press Release) 20:17 Tue, 13 Oct

Will Skyrizi & Rinvoq Drive AbbVie's Top-Line Growth in Q3? Zacks 17:21 Mon, 12 Oct

New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Disease AbbVie (Press Release) 18:01 Sun, 11 Oct

Advertisement

Advertisement

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Hot Topics Hot Topics
Australia Australia
World World
Sport Sport
Business Business
Entertainment
Science Science
Technology Technology
Lifestyle Lifestyle